bezlotoxumab place in therapy — Main — tl;dr pharmacy

Posts tagged bezlotoxumab place in therapy

New FDA Approval: Zinplava

New FDA Approval: Zinplava

Drug

Bezlotoxumab [Zinplava]

Indication

To reduce the recurrence of Clostridium difficile infection (CDI) in patients 18 years old and over.

FDA Approval, Clinical, Pharmacy School, PracticeBrandon DysonDecember 4, 2016zinplava place in therapy, zinplava, bezlotoxumab, bezlotoxumab place in therapy, zinplava adverse effects, bezlotoxumab adverse effects